impact factor
logo
 

Letters to the Editor

 

Early tocilizumab treatment could improve survival among COVID-19 patients


1, 2, 3, 4, 5, 6

 

  1. Department of Pharmacy, Hospital de Mataró, CSdM, Mataró, Barcelona, Spain. lcampins@csdm.cat
  2. Department of Internal Medicine, Hospital de Mataró, CSDM, Mataró, Barcelona; Grup d’Estudi al Maresme de la Pneumònia Adquirida en la Comunitat i la MPOC (GEMP@C), Mataró, Barcelona; and Universidad de Barcelona, CIBERES Barcelona, Spain.
  3. Department of Pharmacy, Hospital de Mataró, CSdM, Mataró, Barcelona, Spain.
  4. Department of Internal Medicine, Hospital de Mataró, CSDM, Mataró, Barcelona, Spain.
  5. Department of Internal Medicine, Hospital de Mataró, CSDM, Mataró, Barcelona, Spain.
  6. Department of Internal Medicine, Hospital de Mataró, CSDM, Mataró, Barcelona, and ESCS-TCMM, Pompeu Fabra University, Mataró, Barcelona, Spain.

CER13578
2020 Vol.38, N°3
PI 0578
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 32456769 [PubMed]

Received: 17/05/2020
Accepted : 20/05/2020
In Press: 27/05/2020
Published: 27/05/2020

Rheumatology Article